Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2006 Sep 1.

Published in final edited form as: JAMA. 2006 Mar 1;295(9):1033–1041. doi: 10.1001/jama.295.9.1033

Cumulative incidence of A. atrial fibrillation, B. coronary heart disease, C. cerebrovascular disease, and D. death from all causes over the 13 years of follow-up, according to thyroid status. Number at risk for atrial fibrillation plot: n=47 for subclinical hyperthyroid, 2502 for euthyroid, 472 for subclinical hypothyroid, and 49 for hypothyroid. Number at risk for coronary heart disease, cerebrovascular disease, and mortality plots: n=31 for subclinical hyperthyroid, 1838 for euthyroid, 347 for subclinical hypothyroid, and 30 for hypothyroid. P<.001 for comparison of atrial fibrillation incidence between subclinical hyperthyroid and euthyroid groups. P=.02 for comparison of mortality between subclinical hyperthyroid and euthyroid groups. All other comparisons are not statistically significant.

Cumulative incidence of A. atrial fibrillation, B. coronary heart disease, C. cerebrovascular disease, and D. death from all causes over the 13 years of follow-up, according to thyroid status. Number at risk for atrial fibrillation plot: n=47 for subclinical hyperthyroid, 2502 for euthyroid, 472 for subclinical hypothyroid, and 49 for hypothyroid. Number at risk for coronary heart disease, cerebrovascular disease, and mortality plots: n=31 for subclinical hyperthyroid, 1838 for euthyroid, 347 for subclinical hypothyroid, and 30 for hypothyroid. P<.001 for comparison of atrial fibrillation incidence between subclinical hyperthyroid and euthyroid groups. P=.02 for comparison of mortality between subclinical hyperthyroid and euthyroid groups. All other comparisons are not statistically significant.